THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

HSBC HOLDINGS PLC's Holding History (CIK: 0000873630)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 18,477 Value ($000) $354 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 48,917 Value ($000) $719 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 57,214 Value ($000) $638 Avg Close $9.72 Range $7.90 - $11.82
Q2 2024
Shares 12,829 Value ($000) $108 Avg Close $9.03 Range $8.13 - $10.44
Q1 2021
Shares 10,412 Value ($000) $210 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 12,130 Value ($000) $212 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 12,130 Value ($000) $183 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 12,130 Value ($000) $254 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 12,904 Value ($000) $298 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 9,145 Value ($000) $240 Avg Close $19.43 Range $15.72 - $26.47
Q4 2016
Shares 6,914 Value ($000) $220 Avg Close $31.02 Range $24.54 - $38.92